Preoperative administration of eculizumab to prevent surgery‐triggered hemolysis during cesarean section with paroxysmal nocturnal hemoglobinuria

Eculizumab in pregnancy has been reported to be effective in improving outcomes in patients with paroxysmal nocturnal hemoglobinuria. However, a cesarean section may result in surgery‐triggered hemolysis. An additional dose of eculizumab just prior to delivery is an appropriate choice to prevent pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dongping, Wang, Liangcheng, Horiuchi, Isao, Kimura, Shun‐ichi, Chikazawa, Kenro, Kimura, Azusa, Sasaki, Shigetane, Kuwata, Tomoyuki, Takagi, Kenjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132156/
https://www.ncbi.nlm.nih.gov/pubmed/30214768
http://dx.doi.org/10.1002/ccr3.1707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132156/
https://www.ncbi.nlm.nih.gov/pubmed/30214768
http://dx.doi.org/10.1002/ccr3.1707

Ejemplares similares